The stock of Immunotec Inc (CVE:IMM) hit a new 52-week high and has $1.17 target or 192.00% above today’s $0.40 share price. The 8 months bullish chart indicates low risk for the $28.26M company. The 1-year high was reported on Sep, 14 by Barchart.com. If the $1.17 price target is reached, the company will be worth $54.26M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock closed at $0.4 during the last session. It is up 6.00% since August 15, 2016 and is uptrending. It has underperformed by 10.49% the S&P500.
Immunotec Inc. is a Canada-based company that develops, makes, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the United States and Mexico. The company has a market cap of $28.26 million. The Firm also subcontracts certain distribution logistics and manufacturing capacity activities in the United States, Europe and Mexico to support its activities. It has a 7.35 P/E ratio. It makes and sells natural health products, dietary supplements and cosmetics, and sells them under a network marketing business model.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.